Bio-Techne and MedSanTek Team Up to Boost Research in Turkey and Azerbaijan
Bio-Techne and MedSanTek Team Up to Boost Research in Turkey and Azerbaijan
Bio-Techne Corporation (NASDAQ:TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities today announced a partnership with MedSanTek. Under the agreement, MedSanTek becomes the distributor of Bio-Techne's R&D Systems, Novus, Tocris, Protein Simple, Advanced Cell Diagnostics (ACD), and Asuragen brands across Turkey.
Bio-Techne公司（納斯達克：TECH）是一家全球生命科學公司，爲研究和臨床診斷界提供創新工具和生物活性試劑，今天宣佈與MedSanTek達成合作夥伴關係。根據協議，MedSanTek成爲Bio-Techne的R&D系統、Novus、Tocris、Protein Simple、愛文思控股電芯診斷（ACD）和Asuragen品牌在土耳其的分銷商。
Founded in the late 2000s, MedSanTek is a leading in vitro diagnostics and research products distributor, serving Turkey and Azerbaijan. Partnering with global brands, the company provides high-quality solutions in molecular biology, immunology, cancer research, cell therapy, and more, earning a reputation for innovation and customer satisfaction in advancing science and healthcare.
MedSanTek成立於2000年代末，是一家領先的體外診斷和研究產品分銷商，服務於土耳其和阿塞拜疆。該公司與全球品牌合作，提供分子生物學、免疫學、抗癌醫藥、細胞治療等領域的高質量解決方案，因在推進科學和醫療保健方面的創新和客戶滿意度而享有聲譽。
譯文內容由第三人軟體翻譯。